PIK3CB and breast cancer: In order to determine whether the same changes described in cells only partially sensitive to inhibition of PI3K pathway were taking place also in models of acquired resistance, we derived drug‐resistant variants from breast cancer cell lines that normally exhibit high sensitivity to PI3K inhibition in vitro, such as HCC70 and ZR‐751.